Internuclear Ophthalmoplegia

• Disruption of the MLF crossing fibers: The MLF contains crossing fibers from the contralateral abducens nucleus (CN VI) that project to the ipsilateral oculomotor nucleus (CN III), mediating adduction of the ipsilateral eye during conjugate horizontal gaze. A lesion in the MLF interrupts this crossing pathway, preventing the adduction signal from reaching the medial rectus subnucleus of the oculomotor nucleus. The result is paresis or paralysis of ipsilateral eye adduction during voluntary horizontal gaze toward the opposite side. Importantly, the crossing fibers synapse on internuclear neurons that excite the medial rectus motor neurons, so disruption at any point along this pathway produces the same clinical picture. The lesion can occur anywhere from the lower pons (just after fibers emerge from the abducens nucleus) through the rostral midbrain before reaching the oculomotor nucleus.

• Preservation of convergence pathway: The convergence pathway (near response) utilizes a separate anatomical route from the medial longitudinal fasciculus. Convergence signals originate from the rostral midbrain (Edinger-Westphal nucleus and medial rectus subnuclei) and reach the medial rectus muscles via direct, uncrossed connections that do not traverse the MLF. This explains the pathognomonic finding of preserved adduction during convergence despite impaired adduction during horizontal gaze—a dissociation that is diagnostic of MLF pathology and distinguishes INO from other causes of adduction deficits (such as CN III palsy, where convergence is also affected). The preserved convergence serves as powerful evidence that motor function of the medial rectus is intact and the lesion is specifically in the conjugate gaze pathway.

• Nystagmus of the contralateral abducting eye: The ipsilateral lesion affects the inhibition of the contralateral abducens nucleus through the MLF. During conjugate gaze to the opposite side, the contralateral abducens nucleus receives drive to move the opposite eye outward (abduction). Normally, the ipsilateral MLF would carry signals to inhibit further firing of the contralateral abducens nucleus to prevent overshoot. With MLF disruption, this inhibitory input is lost, resulting in dissociated nystagmus of the abducting (contralateral) eye—typically a unidirectional or bidirectional nystagmus. This occurs because the abducens nucleus continues to fire beyond the normal setpoint, causing the abducting eye to overshoot and oscillate. The adducting (ipsilateral) eye remains relatively still because it is already paretic.

• Monocular eye movement preservation: Vertical eye movements and convergence (testing medial rectus function through a different anatomical pathway) remain intact because they do not depend on the MLF. Similarly, smooth pursuit and saccades initiated by other brainstem and midbrain structures bypass the affected pathway. This preservation of other eye movements despite selective loss of horizontal adduction is crucial diagnostically and confirms the focal nature of the lesion to the MLF.

• One-and-a-half syndrome: When MLF lesions are bilateral or when combined with ipsilateral paramedian pontine reticular formation (PPRF) or abducens nucleus involvement, patients develop "one-and-a-half syndrome." This consists of complete horizontal gaze palsy to one side (loss of ipsilateral gaze from PPRF/CN VI lesion) plus INO contralateral to that side (loss of contralateral adduction from ipsilateral MLF lesion). The patient retains only convergence and vertical eye movements.

• Multiple sclerosis (most common in patients <50 years): MS accounts for approximately 40-50% of INO cases in younger populations and represents the classic association for board exams. The demyelinating lesion disrupts the myelin sheath surrounding axons within the MLF, causing conduction block. MS-related INO often occurs as a presenting manifestation; bilateral INO (occurring in 5-10% of MS patients with INO) is virtually pathognomonic for demyelinating disease and almost never occurs with vascular disease. The demyelinating lesions in MS are typically at the level of the lower midbrain or rostral pons, where the MLF is anatomically compact. Patients with MS-associated INO typically recover substantially over weeks to months as inflammation resolves and remyelination occurs, though some residual deficits may persist.

• Cerebrovascular disease (predominant in patients >50 years): Small vessel disease, including lacunar infarcts, represents the most common etiology in older patients, accounting for 30-40% of INO cases in this population. Vascular lesions typically affect the MLF at the pontomedullary junction or lower pons. Risk factors include hypertension, diabetes mellitus, hyperlipidemia, smoking, and atrial fibrillation. Vascular INO typically has acute onset and slower or incomplete recovery compared to demyelinating causes. Large artery disease and cardioembolic stroke can also cause INO but are less common.

• Brainstem infarction from vertebral artery dissection: Vertebral artery dissection can produce INO as part of a broader brainstem syndrome, particularly when the dissection extends into the intracranial vertebral artery and affects perforating vessels supplying the MLF. This etiology should be considered in younger patients with acute INO, especially those with recent neck trauma (even minor trauma), manipulation, or sudden head turning. Imaging with MRI with fat-saturation sequences or CT angiography can identify the dissection.

• Other demyelinating diseases: While MS is the most common demyelinating cause, neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease, and acute disseminated encephalomyelitis (ADEM) can rarely produce INO as part of their clinical spectrum. These diagnoses should be considered when additional clinical features or serologies suggest alternative demyelinating pathology.

• Metabolic and toxic causes: Wernicke encephalopathy (thiamine deficiency) classically presents with ophthalmoplegia and can mimic INO, though it typically produces other findings (ataxia, confusion, nystagmus) that help distinguish it. Pontine lesions from thiamine deficiency specifically can affect the MLF. Alcoholism is the primary risk factor.

• Tumor or structural lesions: Brainstem tumors, syrinx, or other mass lesions can compress or infiltrate the MLF, producing INO as part of a syndrome with other focal neurological deficits. Progressive course over weeks to months helps distinguish structural lesions from acute demyelinating or vascular causes.

• Infection: Brainstem encephalitis from infectious causes (viral, particularly enterovirus or HSV) or inflammatory conditions can produce INO, though this is rare. Syphilis and Lyme disease (in endemic regions) can rarely affect the brainstem.

• Trauma: Traumatic brainstem injury can disrupt the MLF, typically in the context of severe head injury with obvious other brainstem signs.

• Impaired ipsilateral eye adduction during contralateral gaze (cardinal finding): When the patient attempts to look toward the opposite side (e.g., looking left in right INO), the right eye fails to adduct appropriately across the midline. The eye may remain in a midline or slightly abducted position while the contralateral eye abducts normally. This occurs because the rightward (leftward) gaze command must cross the midline through the ipsilateral (right) MLF to reach the medial rectus subnucleus. The adduction deficiency may be complete (total paralysis of adduction) or partial (slowed or weak adduction). Asking the patient to follow your finger moving toward the nose (convergence) immediately demonstrates intact adduction, providing the pathognomonic dissociation.

• Preserved adduction during convergence (pathognomonic finding): When the patient fixates on your finger approaching the nose, both eyes converge normally with intact adduction. This is the sine qua non of MLF lesions and definitively excludes CN III palsy (where convergence would also be impaired) or primary medial rectus weakness. The preserved convergence indicates that the medial rectus muscle itself is functioning normally, the oculomotor nerve is intact, and only the MLF pathway is disrupted. Testing convergence is therefore essential in every patient with suspected INO.

• Contralateral eye nystagmus during gaze away from lesion: The eye opposite the MLF lesion (the abducting eye) develops dissociated nystagmus—typically unidirectional nystagmus beating away from midline. This occurs because loss of MLF-mediated inhibition allows the contralateral abducens nucleus to overfire, causing overshoot and compensatory back-saccades. The adducting (ipsilateral) eye remains relatively quiet. This dissociated nystagmus—present in the opposite eye from the adduction defect—is a key finding that helps localize the lesion to the MLF rather than to other structures.

• Normal vertical eye movements and pupillary responses: Vertical gaze (up and down) remains intact because vertical eye movements are mediated by the rostral interstitial nucleus of the MLF (riMLF) and interstitial nucleus of Cajal in the midbrain, which are anatomically distinct from the horizontal pathway through the MLF. Pupils are normal unless additional midbrain pathology is present. This preservation of vertical function is diagnostically important.

• Monocular horizontal saccadic slowing: Some patients with INO, particularly those with demyelinating causes, may show slowing of saccades in the adducting eye specifically, with slowed velocity. This reflects incomplete demyelination or mild conduction delay in the MLF.

• Symptom onset and temporal profile: In demyelinating INO (MS), symptoms often develop acutely over minutes to hours. Patients may report sudden onset of blurred or double vision (diplopia), particularly diplopia that worsens when looking away from the lesion. In vascular causes, onset is typically equally acute but prognosis for recovery is worse. Some patients report dizziness or vertigo if associated brainstem structures are affected. Importantly, many patients with mild INO may not spontaneously report visual symptoms, and the finding is only elicited on formal eye movement testing.

• Atypical presentations and variants: "Wall-eyed" bilateral INO (WEBINO) occurs when bilateral INO is associated with vergence insufficiency, producing a characteristic divergent strabismus at rest. One-and-a-half syndrome (discussed above) produces much more dramatic eye movement restriction. Patients with partial INO may show slowed adduction rather than frank paralysis. Some patients have selective impairment of certain types of saccades (e.g., volitional saccades impaired while reflexive saccades preserved) or asymmetric bilateral INO.

• Clinical eye movement testing (diagnostic gold standard): The bedside examination establishes the diagnosis through observation of characteristic findings: (1) Impaired ipsilateral eye adduction during contralateral gaze—observe the eye movement pattern as patient tracks your finger moving left and right; (2) Preserved adduction during convergence—have patient fixate on your finger as it approaches the nose at midline; (3) Dissociated nystagmus of contralateral (abducting) eye—observe the nystagmus beating away from midline during gaze away from the lesion. The dissociation between impaired gaze-evoked adduction and preserved convergence adduction is diagnostic and not seen with other causes of eye movement disorders. Sensitivity of clinical diagnosis approaches 95% when all components are systematically tested.

• Magnetic resonance imaging (MRI) of the brain with focus on brainstem: MRI is the neuroimaging modality of choice for evaluating INO and determining etiology. T2-weighted and FLAIR sequences are most sensitive for detecting MLF lesions. In demyelinating disease (MS), the lesion appears as a hyperintense signal in the MLF on T2/FLAIR, typically located at the lower midbrain or rostral pons level. The lesion is usually small (a few millimeters) and may be subtle. In acute demyelinating lesions, postgadolinium T1 imaging may show enhancement, indicating disruption of the blood-brain barrier. In vascular disease, the lesion appears as a hyperintense signal on T2 and restricted diffusion (hyperintense) on diffusion-weighted imaging (DWI), reflecting acute ischemia. DWI is particularly useful for acute vascular lesions, showing signal abnormality within hours of symptom onset, whereas conventional T2 imaging may initially appear normal. Sensitivity of MRI for detecting acute pontine lesions is approximately 80-90%, though small lesions may occasionally be missed on standard sequences.

• Brain MRI protocol considerations: For suspected INO, request brain MRI with high-resolution imaging through the brainstem, including T2-weighted, FLAIR, and DWI sequences. For evaluation of MS, additional T1-weighted imaging with gadolinium and imaging of the cervical spinal cord are warranted per MS diagnostic criteria. For acute stroke evaluation, DWI/perfusion imaging is essential. The specific protocol should be guided by the clinical context (acute vs. subacute presentation, age of patient, clinical suspicion for MS vs. stroke).

• Cerebrospinal fluid (CSF) analysis: CSF examination is not diagnostic of INO itself but may support demyelinating disease etiology. In MS, CSF typically shows: oligoclonal bands (OCB) present in 85-95% of MS patients (though less sensitive in early disease), elevated IgG index, and elevated myelin basic protein (MBP) acutely. Pleocytosis with lymphocytic predominance may be present. CSF analysis is typically performed when MS is the suspected etiology, particularly if MRI findings are nondiagnostic or atypical. However, CSF analysis is not routinely needed for diagnosis of the INO itself.

• Serum and CSF testing for demyelinating disease: Anti-aquaporin-4 (AQP4) antibodies and anti-MOG antibodies should be tested if NMOSD or MOG-associated disease is in the differential diagnosis, particularly in patients with bilateral INO or INO with atypical features. These tests help refine diagnosis and guide treatment. Standard MS diagnostic criteria (2017 McDonald Criteria) integrate clinical, MRI, and CSF findings; isolated INO may not meet full MS criteria until additional dissemination in space and time is documented.

• Neurophysiology (less commonly used): Electronystagmography (ENG) or videonystagmography (VNG) can objectively document the dissociated nystagmus and quantify eye movement velocities, confirming the pattern observed clinically. These are most useful in research settings or when clinical findings are ambiguous. Electrooculography (EOG) may show slowed saccadic velocity in the adducting eye.

• Vascular imaging when stroke suspected: For patients >50 years with acute INO and vascular risk factors, or any patient with acute INO and acute DWI lesion on brain MRI, additional vascular imaging is warranted. CT angiography (CTA) or MR angiography (MRA) of the neck and intracranial vessels can identify large artery disease, dissection, or other vascular pathology. Cardiac imaging (echocardiography, cardiac MRI, or telemetry) may be indicated if cardioembolic source

Immediate stabilization

• Acute stroke pathway: If onset is acute and DWI shows restricted diffusion, manage per the AHA/ASA Acute Ischemic Stroke guideline — fingerstick glucose, non-contrast head CT to exclude hemorrhage, and consideration of IV thrombolysis (alteplase or tenecteplase) within the approved time window. Posterior-circulation and "minor but disabling" deficits such as diplopia are not automatic exclusions. Blood pressure must be lowered below the guideline threshold before lysis, typically with a short-acting IV agent (labetalol or nicardipine). Mechanical thrombectomy applies only to large-vessel occlusion, not to an isolated perforator lesion.
• Thiamine before glucose: In any malnourished or alcohol-using patient with ophthalmoplegia, give parenteral thiamine before dextrose to avoid precipitating Wernicke encephalopathy.

First-line therapy by etiology

• Demyelinating relapse (MS): High-dose corticosteroids — IV methylprednisolone (or bioequivalent high-dose oral) for several days — shorten relapse duration, consistent with AAN practice recommendations. Steroids speed recovery but do not change long-term disability.
• Secondary stroke prevention: Antiplatelet therapy (aspirin, or aspirin plus clopidogrel short-course for qualifying minor stroke/TIA) plus high-intensity statin and risk-factor control per AHA/ASA; anticoagulation if atrial fibrillation is found.

Escalation

• Plasma exchange for corticosteroid-refractory severe demyelinating attacks (AAN).
• Disease-modifying therapy for confirmed MS once 2017 McDonald criteria are met (AAN DMT guideline); AQP4-IgG or MOG-IgG positivity mandates different agents.

Definitive/symptomatic management

• Prisms, monocular occlusion, or strabismus surgery only for stable, persistent diplopia after months without recovery.

Contraindicated/avoid

• Interferon-beta and other MS DMTs in AQP4-positive NMOSD — they can worsen disease.
• Glucose before thiamine; thrombolysis with active hemorrhage or uncontrolled hypertension; empiric steroids before excluding CNS infection or lymphoma.

Complications of the disease

• Disabling binocular diplopia and oscillopsia: Loss of conjugate horizontal gaze plus dissociated nystagmus in the abducting eye produces image separation and apparent motion of the visual world; signaled by patients closing or patching one eye. Chronic cases risk falls and driving restriction.
• Extension of the brainstem lesion: The MLF lies adjacent to the PPRF, abducens nucleus, and medial lemniscus. Progression to one-and-a-half syndrome (only contralateral abduction preserved) or to crossed motor/sensory signs, dysarthria, or depressed consciousness signals an enlarging pontine infarct or basilar artery thrombosis — a neurologic emergency requiring immediate vascular imaging, since basilar occlusion can progress to locked-in syndrome or death.
• WEBINO: Bilateral INO with exotropia in primary gaze from bilateral MLF plus vergence involvement; strongly suggests demyelination or rostral midbrain pathology.
• Vertebral artery dissection with embolic extension: New neck or occipital pain with an expanding deficit; emergency vascular imaging is indicated.
• Conversion to clinically definite MS: INO as a clinically isolated syndrome with disseminated T2 lesions predicts future relapses and accumulating disability.
• Korsakoff amnesia: If the ophthalmoplegia was thiamine-related and treatment was delayed, irreversible confabulatory amnesia follows.

Complications of treatment

• Corticosteroids: hyperglycemia (worst in diabetics), insomnia and steroid psychosis, hypertension, gastritis, opportunistic infection, and with repeated courses avascular necrosis of the femoral head — hip or groin pain warrants MRI.
• Plasma exchange: citrate-induced hypocalcemia (perioral tingling, Chvostek sign), hypotension, and central-line complications including pneumothorax and catheter infection.
• Thrombolysis: symptomatic intracranial hemorrhage — sudden headache, vomiting, or neurologic decline demands stopping the infusion and emergent non-contrast CT — plus orolingual angioedema, an airway emergency.
• MS disease-modifying therapies: natalizumab-associated PML (new cognitive or focal deficits with non-enhancing white matter lesions), sphingosine-1-phosphate modulator first-dose bradycardia, and anti-CD20 hypogammaglobulinemia with infection.

• The triad that names the lesion: failure of adduction on contralateral gaze + dissociated nystagmus of the abducting eye + intact convergence = MLF lesion. The side of the adduction deficit is the side of the lesion.
• Age splits the etiology: young patient, especially a woman with prior optic neuritis or sensory symptoms → multiple sclerosis; older patient with hypertension and diabetes and abrupt onset → pontine lacunar infarct. Bilateral INO is MS until proven otherwise.
• Single best next step: MRI brain with DWI and thin cuts through the brainstem, not CT — CT poorly visualizes the pons and misses both demyelinating plaques and hyperacute infarcts.
• The distractor to avoid — CN III palsy: a third nerve palsy also fails to adduct, but convergence is lost, and ptosis, a "down-and-out" eye, and pupillary involvement accompany it. Preserved convergence excludes it.
• The second distractor — myasthenia gravis can produce pseudo-INO. Look for fatigability, diurnal variation, ptosis with Cogan lid twitch, and normal MRI; check acetylcholine receptor antibodies.
• One-and-a-half syndrome = ipsilateral PPRF/abducens nucleus lesion plus ipsilateral MLF lesion: complete horizontal gaze palsy to one side and INO to the other, leaving only contralateral abduction (with nystagmus) — the "half."
• Vertical gaze and pupils are normal in pure INO; if vertical gaze is impaired, think dorsal midbrain (Parinaud) or riMLF pathology instead.
• Treatment is of the cause, not the sign: IV methylprednisolone for a demyelinating relapse per AAN practice recommendations; the AHA/ASA acute stroke pathway with thrombolysis eligibility assessment for an acute infarct. Prisms or strabismus surgery are reserved for stable, chronic diplopia.
• Ophthalmoplegia + ataxia + confusion in an alcohol-using patient: give thiamine before glucose — Wernicke encephalopathy, not MS.